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Abstract
Background: Retinal detachment is more common among uveitis patients than in the general population. Here,
we aimed to assess the prevalence of rhegmatogenous retinal detachment (RRD) in a uveitis population.
Methods: We retrospectively studied 851 uveitis patients, recording characteristics such as uveitis duration,
anatomical location, and cause; RRD occurrence; proliferative vitreoretinopathy (PVR) at presentation; surgical
approach; reattachment rate; and initial and final visual acuity (VA).
Results: RRD occurred in 26 patients (3.1%; 29 affected eyes) and was significantly associated with posterior uveitis
(p < 0.001), infectious uveitis (p < 0.001), and male gender (p = 0.012). Among cases of infectious uveitis,
cytomegalovirus and varicella zoster virus were most commonly associated with RRD development. RRD in non-
infectious uveitis was not found to be associated with any specific uveitis entity. The rate of single-operation
reattachment was 48%, and the rate of final reattachment was 83%. Mean final VA was 20/125, with 41% of eyes
ultimately having a VA of less than 20/200.
Conclusion: Uveitis is a risk factor for RRD development, which carries a poor prognosis.
Background
Retinal detachment (RD) is a common complication
among patients with uveitis [1]. Serous RD typically oc-
curs in Vogt-Koyanagi-Harada disease and may also be a
complication of severe scleritis, while tractional RD
often develops as a complication of vitritis or chorioreti-
nitis scarring with retinal traction. Rhegmatogenous ret-
inal detachment (RRD) seems to predominantly occur in
patients with retinitis-associated posterior uveitis [2].
The prevalence of RRD among uveitis patients is re-
ported as 3.1%, whereas the incidence of retinal detach-
ment in the general Dutch population is around 18 per
100,000 [3–8]. Herein, we describe the up-to-date inci-
dence of RRD in a uveitis population as well as its asso-
ciations with diverse general and ocular characteristics.
Methods
We retrospectively studied 851 consecutive patients with
uveitis (not necessarily newly diagnosed) who visited the
Erasmus Medical Center Rotterdam between September
2011 and August 2013 (Table 1). The study excluded
patients with serous retinal detachments (n = 12) and
those with retinal tears but without RD (n = 12). This
study was approved by the institutional review board
(waived).
All patients underwent a standardized diagnostic in-
vestigation, which was tailored according to inflamma-
tion localization. This protocol included radiologic chest
examination, erythrocyte sedimentation rate, blood
counts, serum angiotensin-converting enzyme levels,
serology for syphilis and Borrelia, and interferon-gamma
release assay test (IGRA; QuantiFERON–TB Gold In-
Tube test). Patients with anterior uveitis and panuveitis
also underwent human leukocyte antigen-B27 testing.
Some patients underwent additional examinations based
on clinical manifestations.
Behçet’s disease and ocular sarcoidosis were diagnosed
using accepted international criteria [9–11]. Briefly, defini-
tive ocular sarcoidosis was diagnosed in patients with
histological confirmation. Presumed sarcoidosis was diag-
nosed in patients with chest imaging suggestive of sarcoid-
osis and without another explanation for the uveitis, but
without histological proof. A diagnosis of tuberculosis-
associated uveitis required a positive culture for mycobac-
teria in any fluid/tissue sample, while a diagnosis of
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presumed ocular tuberculosis was based on a positive tuber-
culin skin test and/or IGRA test in the presence of otherwise
unexplained uveitis. Ocular toxoplasmosis was only diag-
nosed when proven by intraocular fluid assessment (PCR
and Goldmann-Wittmer Coefficient) [12–15]. Presumed
ocular toxoplasmosis was diagnosed in cases showing typical
clinical features of unilateral focal necrotizing retinitis, which
are sometimes associated with typical old pigmented scars.
All other specific diagnoses were based on current diagnos-
tic criteria. Definitive anatomical classification (e.g.,
localization and laterality of uveitis) was performed
according to the guidelines of the Standardization of Uveitis
Nomenclature (SUN) Working Group [16].
Diagnoses were grouped into infectious and non-
infectious diseases and into established clinical ocular
syndromes, such as pars planitis and birdshot chorioreti-
nopathy. Patients with established ocular syndromes and
an identified cause or association with a systemic disor-
der—for example, multiple sclerosis with pars planitis or
documented rubella virus infection in Fuchs heterochro-
mic uveitis syndrome (FHUS)—were classified according
to the specific cause of their uveitis.
Table 1 General and ocular characteristics of patients with uveitis with and without rhegmatogenous retinal detachment
Uveitis with RRD N = 26 Uveitis without RRD N = 825 p valuea
Mean age at onset uveitis (years) 46 43
Male/female ratio 17/9 322/503 0.007
Location
Anterior 6 (23%) 342 (41%) 0.061
Intermediate 0 79 (10%) 0.098
Posterior 15 (58%) 183 (22%) < 0.001
Panuveitis 5 (19%) 200 (24%) 0.556
Scleritis 0 21 (3%) 0.410
Infectious uveitis
Total 14 110 < 0.001
HSV 1 (4%)e 17 (2%) 0.533
VZVb 3 (12%)f 9 (1%) < 0.001
CMVc 6 (23%)g 10 (1%) < 0.001
Toxoplasma 2 (8%) 23 (3%) 0.145
Presumed and definitive TB 1 (4%) 24 (3%) 0.781
Candida 1 (4%) 8 (1%) 0.158
Otherd 0 19 (2%) 0.434
Association with systemic disease
Sarcoidosis 3 (12%)h 88 (10%) 0.887
HLA-B27 associated AAU 1 (4%) 70 (8%) 0.400
JIA 1 (4%) 30 (4%) 0.955
Behçet’s disease 1 (4%) 23 (3%) 0.748
VKH 1 (4%) 6 (1%) 0.083
Other 0 101 (12%) 0.057
Established ocular entity
Birdshot chorioretinopathy 1 (4%) 30 (4%) 0.955
Other 0 30 (4%) 0.322
Unknown 5 (19%) 337 (41%) 0.020
RRD rhegmatogenous retinal detachment, HSV herpes simplex virus, VZV varicella zoster virus, CMV cytomegalovirus, TB tuberculosis, HLA human leukocyte
antigen, AAU acute anterior uveitis, JIA juvenile idiopathic arthritis, VKH Vogt-Koyanagi-Harada disease
aA p value of less than 0.05 was considered statistically significant
bOne VZV patient had bilateral RRD
cTwo CMV patients had bilateral involvement
dIncludes infections with Rubella virus, Treponema pallidum, and Borrelia burgdorferi
eThis patient had active uveitis presenting with RRD
fOne of the VZV cases (bilateral) had active inflammation presenting with RRD
gAll of the CMV cases had active uveitis presenting with RRD
hOne case with sarcoidosis had active uveitis presenting with RRD
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For the population of patients with RRD and uveitis,
we recorded various factors such as age; sex; uveitis lat-
erality, location, and cause; uveitis duration before RRD;
and prior intraocular surgery. Our series was treated by
multiple vitreoretinal surgeons using variable surgical
approaches, precluding reliable and precise classification
of specific surgical techniques. Statistical analyses in-
cluded the chi-square test and t test, performed using
SPSS statistical software.
Results
Among the 851 investigated patients with uveitis, 26
(3.1%) developed RRD in a total of 29 eyes (three patients
developed bilateral RRD). Table 1 presents the general and
ocular characteristics of patients with and without RRD.
The mean age at uveitis onset was 46 years in the RRD
subset, compared to 43 years in the non-RRD group (p =
0.375). The mean age at RRD onset was 48 years. While
uveitis patients without RRD were more commonly female
(503/825; 61%), the majority of patients in the RRD group
were male (65%) (p = 0.012). The mean duration of uveitis
prior to RRD was 34 months (range, 0–228 months).
Mean follow-up duration after RRD was 111, 4 months
(range, 0–560 months).
Out of 29 eyes with RRD, 10 (34%) had active uveitis
within 3 months before surgery (9 with viral retinitis and
1 associated with sarcoidosis). Reliable data regarding
uveitis activity were unavailable for four eyes (14%). RRD
was predominantly associated with posterior uveitis (15/
183 patients versus 11/642 patients, p < 0.001), while an-
terior uveitis was associated with less frequent RRD de-
velopment. All three patients with bilateral RRD had
uveitis of the same cause in both eyes: two patients had
bilateral cytomegalovirus (CMV)-related posterior uve-
itis, and one had bilateral varicella zoster virus (VZV)-
related posterior uveitis.
RRD patients more commonly had uveitis due to in-
fectious causes (14/26 versus 110/825; p < 0.001). Within
the group of patients having infectious uveitis, CMV ret-
initis was predominantly associated with RRD develop-
ment (8/29 eyes, 28%) followed by VZV (4/29 eyes, 14%)
(p < 0.001 for both).
Of the 29 eyes with RRD, 9 (31%) had undergone pre-
vious intraocular surgery, comprising four cataract ex-
tractions, two phaco-vitrectomies (for macular puckers),
one vitrectomy alone (for floaters), one trabeculectomy
alone, and one trabeculectomy that was followed by vi-
trectomy (for floaters). Of the six eyes with RRD in the
anterior uveitis group, three had previously undergone
uncomplicated intraocular surgery, one of which was
also highly myopic (~S−10).
Proliferative vitreoretinopathy (PVR) was present at
RRD presentation in 7/29 eyes (24%). Three of these
eyes exhibited PVR both before and after surgery,
whereas four eyes had developed new PVR after initial
surgery.
The mean number of surgical procedures for uveitic
RRD was 1.6. Single-operation reattachment was achieved
in 14/29 eyes (48%). In 24/29 (83%) eyes, the retina was
reattached after additional surgical procedures. In 4/29
eyes (14%), the silicone oil could not be removed due to
hypotony or persistent detachment. One eye did not
undergo surgery due to a very poor prognosis.
The mean best corrected visual acuity (BCVA) was 20/
32 before RRD and was 20/80 in eyes with RRD just
prior to surgery. The mean final VA was 20/125. Of the
29 eyes with RRD, 12 (41%) ultimately had a VA of less
than 20/200, including 3 eyes with only hand move-
ments or light perception, and 4 eyes with no light per-
ception. There was no significant difference in visual
outcome between patients with PVR prior to surgery
and those without, nor between viral versus non-viral
causes of uveitis.
Discussion
In our series, RRD occurred in 3.1% of patients with
uveitis, constituting a serious uveitis complication that
was responsible for a final VA of ≤ 20/200 in 12 (41%) of
the 29 eyes affected with uveitic RRD.
The 3.1% prevalence of RRD within our cohort of pa-
tients with uveitis is similar to the prevalence reported
in patients with uveitis in 2003 and is much higher than
the prevalence in the general population. Moreover, 12%
of patients with uveitic RRD in our study showed bilat-
eral involvement. This is substantially higher than the
reported 1.67% rate of bilateral RRD in the non-uveitis
population [3, 4]. Tomkins-Netzer et al. [1] described se-
vere vision loss (≤ 20/200) due to RRD in 1.33% of 1076
uveitis patients, which is very similar to the rate in our
present series (1.4%; 12/852). Additionally, the visual
outcomes among patients with RRD and uveitis were
worse (average 20/125) compared to outcomes in pa-
tients with non-uveitic RRD. In cases of RRD without
uveitis, the mean BCVA after surgery (with macula on
and off ) was between 0.17 and 0.18 logMAR, corre-
sponding to a Snellen VA of 20/30 [17, 18], which is
much better than the outcomes in our present cohort.
Our study was performed during an era of transition
from 20-gauge to 23-gauge and eventually 25-gauge vi-
trectomy. We had incomplete data regarding the specific
surgical approaches used, such as vitrectomy with or
without buckle and/or encircling element or buckling
surgery only, and the specific types of tamponades
employed. Thus, it is not possible to determine the most
efficacious surgical approach based on our data. The
poor visual outcome of RRD in our series of patients
with uveitis might have been partly influenced by severe
co-morbidity with sometimes already compromised
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macular function, ongoing intraocular inflammation, and
possible hypotony. In the future, the continuous evolu-
tion of vitreous surgery might reduce the visual impair-
ment in uveitis patients who develop RRD. Our data
highlight the need for additional investigations, and pref-
erably prospective studies, of the best medical and surgi-
cal approaches for RRD in uveitis.
Our results indicated that uveitic RRD was associated
with a posterior location of uveitis and with infectious
causes, especially viral infections. It is logical that retinal
involvement would be related to RRD development. Ret-
inal necrosis and atrophy related to viral retinal disor-
ders, in combination with vitreous degeneration, fibrotic
changes, and traction encountered in uveitis, likely all
play a role in the development of retinal tears and subse-
quent detachment [19]. This may also explain why all bi-
lateral RRDs occurred in patients with viral retinitis. In
non-infectious disorders, large areas of retinal atrophy
are not common; however, the higher rates of vitreous
shrinkage and posterior vitreous detachments in uveitis
may also contribute to RRD development.
Cytomegalovirus is a well-known cause of RRD. Not-
ably, in the AIDS era, one third of patients with CMV
retinitis developed RRD. In our series, two patients with
CMV retinitis and RRD were HIV-infected and had low
CD4+ leukocyte counts. The other four patients with
CMV retinitis and RRD were receiving immune suppres-
sive therapy for idiopathic thrombocytopenic purpura,
combined with a splenectomy (n = 1), malignant T-cell
lymphoma (n = 1), and after organ transplantation (n =
2). The current literature does not describe mechanisms
that would explain higher RRD rates based solely on the
presence of anterior uveitis. In our study, six patients
with anterior uveitis suffered from RRD, and none of the
above-described risk factors for RRD development seem
to apply in these cases. Among these patients, three had
undergone uncomplicated intraocular surgery prior to
RRD onset, with intervals of 11 months, 1 year, and
5 years between surgery and RRD, which may have con-
tributed to RRD development.
The present study had several limitations, including its
retrospective design. We were unable to adequately as-
sess the prevalence of general risk factors for RRD, such
as high myopia or lattice degeneration, or the exact stage
of PVR before and after surgery. Furthermore, we could
not reliably determine the uveitis activity (including
CME presence) at the time of RRD onset in all cases.
Thus, it was impossible to estimate the number of eyes
that exhibited newly developed CME after surgery. Des-
pite these shortcomings, our results clearly document
the high RRD prevalence in a uveitic population, specif-
ically among patients with posterior and viral uveitis, as
well as highlight a poorer visual outcome of RRD treat-
ment in patients with uveitis. The only other study of
RRD in uveitis was published two decades earlier and re-
ports a similar RRD prevalence. This lack of change is
surprising, as the diagnostic tools and treatment for uve-
itis have improved over this time period, particularly
with the introduction of various novel treatment options
such as anti-TNF drugs and other medications.
In conclusion, our study demonstrates a 3.1% preva-
lence of RRD in the general population of patients with
uveitis from a tertiary center. Our results further high-
light the poor prognosis of uveitic RRD and the need for
improved management of such cases.
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